These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1693252)

  • 1. Putative antigenic domains in glycoprotein G of rabies virus: is the RGK sequence involved in virus adsorption to cellular receptors?
    Becker Y
    Virus Genes; 1990 Feb; 3(3):277-84. PubMed ID: 1693252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CNBr cleavage fragments.
    Dietzschold B; Wiktor TJ; Macfarlan R; Varrichio A
    J Virol; 1982 Nov; 44(2):595-602. PubMed ID: 6183450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of rabies virus mimotopes screened from a phage display peptide library with purified dog anti-rabies virus serum IgG.
    Yang L; Cen J; Xue Q; Li J; Bi Y; Sun L; Liu W
    Virus Res; 2013 Jun; 174(1-2):47-51. PubMed ID: 23499997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence.
    Prehaud C; Coulon P; LaFay F; Thiers C; Flamand A
    J Virol; 1988 Jan; 62(1):1-7. PubMed ID: 2446011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
    Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
    Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein.
    Flamand A; Wiktor TJ; Koprowski H
    J Gen Virol; 1980 May; 48(1):105-9. PubMed ID: 6155432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein.
    Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabies subunit vaccines.
    Wunner WH; Dietzschold B; Curtis PJ; Wiktor TJ
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1649-56. PubMed ID: 6348210
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein.
    van der Heijden RW; Langedijk JP; Groen J; UytdeHaag FG; Meloen RH; Osterhaus AD
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1539-45. PubMed ID: 7688410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.
    Dietzschold B; Wunner WH; Wiktor TJ; Lopes AD; Lafon M; Smith CL; Koprowski H
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):70-4. PubMed ID: 6185960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. e. Infection defense antigens of rabies virus and genetic code].
    Kawai A; Ohkubo A; Morimoto K
    Nihon Rinsho; 1987 Oct; 45(10):2252-7. PubMed ID: 3448264
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
    Sureau P; Rollin P; Lafon M
    Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody.
    Roehrig JT; Hunt AR; Johnson AJ; Hawkes RA
    Virology; 1989 Jul; 171(1):49-60. PubMed ID: 2472704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein.
    Kontsekova E; Macikova I; Novak M; Dedek L; Vrzal V; Kontsek P
    Viral Immunol; 1992; 5(3):213-20. PubMed ID: 1418319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency.
    Lin G; Chen S; Zhao H; Liang J; Deng Q; Liang R; Guo X; Chen Z; Chen B; Liu T; Wu Y
    Sci Rep; 2017 Aug; 7(1):7288. PubMed ID: 28779162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies.
    Dietzschold B; Tollis M; Lafon M; Wunner WH; Koprowski H
    Virology; 1987 Nov; 161(1):29-36. PubMed ID: 3672933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.
    Sun L; Chen Z; Yu L; Wei J; Li C; Jin J; Shen X; Lv X; Tang Q; Li D; Liang M
    Appl Microbiol Biotechnol; 2012 Oct; 96(2):357-66. PubMed ID: 22678022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies.
    Lafon M; Wiktor TJ; Macfarlan RI
    J Gen Virol; 1983 Apr; 64 (Pt 4)():843-51. PubMed ID: 6834008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides.
    Macfarlan RI; Dietzschold B; Wiktor TJ; Kiel M; Houghten R; Lerner RA; Sutcliffe JG; Koprowski H
    J Immunol; 1984 Nov; 133(5):2748-52. PubMed ID: 6332859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals.
    Niederhäuser S; Bruegger D; Zahno ML; Vogt HR; Peterhans E; Zanoni R; Bertoni G
    Vaccine; 2008 Dec; 26(52):6749-53. PubMed ID: 18955098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.